<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Bing Yang | Ray Luo Lab</title><link>http://rayluolab.org/author/bing-yang/</link><atom:link href="http://rayluolab.org/author/bing-yang/index.xml" rel="self" type="application/rss+xml"/><description>Bing Yang</description><generator>Hugo Blox Builder (https://hugoblox.com)</generator><language>en-us</language><lastBuildDate>Thu, 01 Jan 2026 00:00:00 +0000</lastBuildDate><image><url>http://rayluolab.org/media/icon_hu17459977877040264969.png</url><title>Bing Yang</title><link>http://rayluolab.org/author/bing-yang/</link></image><item><title>STK38/L promote tissue growth and cancer by inhibiting the Hippo pathway</title><link>http://rayluolab.org/publication/luo-2026-stk-38-lpromotetissu/</link><pubDate>Thu, 01 Jan 2026 00:00:00 +0000</pubDate><guid>http://rayluolab.org/publication/luo-2026-stk-38-lpromotetissu/</guid><description/></item><item><title>The Hippo pathway kinases LATS1 and LATS2 attenuate cellular responses to heavy metals through phosphorylating MTF1</title><link>http://rayluolab.org/publication/luo-2022-thehippopathwaykin/</link><pubDate>Sat, 01 Jan 2022 00:00:00 +0000</pubDate><guid>http://rayluolab.org/publication/luo-2022-thehippopathwaykin/</guid><description/></item><item><title>Elucidation of WW domain ligand binding specificities in the Hippo pathway reveals STXBP4 as YAP inhibitor</title><link>http://rayluolab.org/publication/luo-2019-elucidationofwwdom/</link><pubDate>Tue, 01 Jan 2019 00:00:00 +0000</pubDate><guid>http://rayluolab.org/publication/luo-2019-elucidationofwwdom/</guid><description/></item><item><title>Regulation of the Hippo Pathway by Phosphatidic Acid-Mediated Lipid-Protein Interaction</title><link>http://rayluolab.org/publication/luo-2018-regulationofthehip/</link><pubDate>Mon, 01 Jan 2018 00:00:00 +0000</pubDate><guid>http://rayluolab.org/publication/luo-2018-regulationofthehip/</guid><description/></item></channel></rss>